A Comparative Study of Breast Tumors Before and After Neoadjuvant Therapy
Diagnostics · 28.10.2026 · 16 (21) · 3548
DOI: 10.3390/diagnostics16213548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 28.10.2026. Verfasst von Adeline-Roxana Bucur und 7 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, E. Murgu Square, No. 2, 300041 Timisoara, Romania. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Victor Babes” University of Medicine and Pharmacy.
Abstract (Originalsprache)
Background
Pathological response after neoadjuvant therapy in breast cancer varies substantially across immunohistochemical surrogate subtypes. This study aimed to compare pretreatment biopsy features with post-treatment surgical pathology findings and to explore baseline predictors of favorable pathological response.
Methods
We retrospectively analyzed female patients with invasive breast carcinoma treated with neoadjuvant therapy followed by surgery at a single institution between January 2020 and December 2024. Pretreatment histological features, stromal tumor-infiltrating lymphocytes, tumor cellularity, necrosis, in situ component, lymphovascular/perineural invasion, and immunohistochemical surrogate subtype were compared with post-treatment findings. Residual disease was assessed using the Residual Cancer Burden system, and vital status was analyzed as an exploratory outcome.
Results
The analytical dataset included 146 breast carcinoma records. RCB-0, RCB-I, RCB-II, and RCB-III were observed in 20, 14, 64, and 46 of 144 evaluable records, respectively, and pCR was identified in 18/142 evaluable records. Tumor cellularity decreased significantly after therapy, whereas stromal TILs and tumor necrosis did not change significantly. Favorable pathological response and pCR were more frequent in HER2-positive and triple-negative tumors than in luminal tumors. In univariable Firth regression, higher baseline stromal TILs and HER2-positive/triple-negative subtype were associated with increased odds of RCB 0/I and pCR, and both associations persisted in multivariable models adjusted for age and grade. Nineteen patients (13.0%) deceased; crude mortality increased across RCB classes (0%, 14.3%, 7.8% and 26.1% for RCB-0 to RCB-III; p = 0.008), with no deaths among patients achieving pCR.
Conclusions
In conclusion, favorable pathological response after neoadjuvant therapy was uncommon in this cohort and was observed mainly in HER2-positive and triple-negative tumors. Baseline stromal TILs and immunohistochemical surrogate subtype showed exploratory associations with response, supporting their further evaluation in larger, treatment-stratified cohorts with formal survival follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral School, "Victor Babes" University of Medicine and Pharmacy Timisoara, E. Murgu Square, No. 2, 300041 Timisoara, Romania.
- Department of Pathology, Emergency City Hospital, 300254 Timisoara, Romania.
- Centre for Artificial Intelligence and Big Data in Emergency Medicine and Clinical Research, Department of Surgery, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
- Department of Microscopic Morphology, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
- University Clinic of Surgery I, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
- Center for Hepato-Bilio-Pancreatic Surgery, "Victor Babes" University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania.
ORCID-Profile: Alexandru Cristian Cindrea, Florin Emil Hut, Flavia Zara
Förderung
- “Victor Babes” University of Medicine and Pharmacy
Zitieren
APA
Bucur, A. R., Cindrea, A. C., Armega-Anghelescu, A., Szeica, P., Porumbel, C. A., Barb, A. C., Hut, F. E., & Zara, F. (2026). A Comparative Study of Breast Tumors Before and After Neoadjuvant Therapy. Diagnostics, 16(21), 3548. https://doi.org/10.3390/diagnostics16213548
Vancouver
Bucur AR, Cindrea AC, Armega-Anghelescu A, Szeica P, Porumbel CA, Barb AC, et al. A Comparative Study of Breast Tumors Before and After Neoadjuvant Therapy. Diagnostics. 2026;16(21):3548. doi:10.3390/diagnostics16213548
BibTeX
@article{Bucur2026,
author = {Bucur, Adeline-Roxana and Cindrea, Alexandru Cristian and Armega-Anghelescu, Antonia and Szeica, Paul and Porumbel, Crina-Andreea and Barb, Alina Cristina and Hut, Florin Emil and Zara, Flavia},
title = {A Comparative Study of Breast Tumors Before and After Neoadjuvant Therapy},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {21},
pages = {3548},
doi = {10.3390/diagnostics16213548}
}
EUVIMED